994 resultados para SEDOHEPTULOSE-7-PHOSPHATE ISOMERASE
Resumo:
Background. Sevelamer is a phosphate-binder used effectively for the treatment of hyperphosphatemia in patients treated with dialysis. Objectives. To describe the safety of sevelamer in children with hyperphosphatemia secondary to tumor lysis syndrome and the serum phosphate concentrations observed following its administration. Procedure. A retrospective chart review of all children with leukemia/lymphoma diagnosed between November 2002 and April 2004 who received sevelamer during their initial admission was conducted. We monitored the effects of sevelamer on serum phosphate concentration, calcium/phosphate product and renal function at hours 24, 48, and 72 from sevelamer initiation. Results. Thirteen patients received sevelamer during the Study period. Their median age was 13 years (range 2.7-17.9) and eight were boys. Nine children had acute lymphoblastic leukemia, one had acute myeloid leukemia and 3 had non-Hodgkin's lymphoma. The most frequently used dose of sevelamer was 400 mg orally twice daily. The median duration of sevelamer therapy was 2 days (range 1 -7). Two children were excluded from the efficacy analysis due to concurrent use of dialysis. Mean serum phosphate levels decreased after sevelamer administration, in eleven patients, from a baseline 2.2 mmol/L +/- 0.4 (95% Cl, 1.7-3.1) to 1.1 mmol/L +/- 0.2 at hour 72 (95%Cl, 0.6-1.5). The only toxicity attributed to sevelamer was mild vomiting in three patients. Conclusions. Sevelamer appears to be effective and tolerable for the treatment of hyperphosphatemia associated with tumor lysis syndrome.
Resumo:
Référence bibliographique : Rol, 54728
Resumo:
Référence bibliographique : Rol, 54723
Resumo:
Référence bibliographique : Rol, 54722
Resumo:
Référence bibliographique : Rol, 55182
Resumo:
Référence bibliographique : Rol, 55180
Resumo:
Référence bibliographique : Rol, 55179
Resumo:
Référence bibliographique : Rol, 55185
Resumo:
Référence bibliographique : Rol, 55191
Resumo:
Référence bibliographique : Rol, 55190
Resumo:
Référence bibliographique : Rol, 55189
Resumo:
Référence bibliographique : Rol, 55186
Resumo:
Référence bibliographique : Rol, 54715
Resumo:
Référence bibliographique : Rol, 54714
Resumo:
A 65 year old alcoholic man was hospitalized because he was tired, hypotonic, with postural tremor. The neurologic symptoms increased during the first two days despite an adequate therapy for alcoholic weaning with hydratation, benzodiazepines and vitamins. A severe hypophosphatemia is diagnosed, associated with hypovitaminosis D, mild hypomagnesemia, mild hypokaliemia and a refeeding syndrome. 24 hours after the normalisation of his phosphatemia, the neurologic symptoms are adjusted.